Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial

AIMS: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) compared with its individual components in Japanese people with type 2 diabetes (T2D) uncontrolled on an oral antidiabetic drug (OAD). MATERIALS AND METHODS: This 52‐week, open‐label, multicentre, treat‐to‐target...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Kaku, Kohei, Araki, Eiichi, Tanizawa, Yukio, Ross Agner, Bue, Nishida, Tomoyuki, Ranthe, Mattis, Inagaki, Nobuya
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2019
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899795/
https://ncbi.nlm.nih.gov/pubmed/31407845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13856
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge